WESTBURY, N.Y.--(BUSINESS WIRE)--Vasomedical, Inc. (“Vasomedical”) (OTC: VASO.OB - News), a leader in the noninvasive treatment and management of cardiovascular diseases, today announced that five presentations on the beneficial effects and the mechanisms of action of EECP® external counterpulsation therapy have been presented at the 57th Scientific Session of the American College of Cardiology in Chicago.
